Analyst firms · Piper Sandler · INSP

Piper Sandler INSP price target and rating history

Inspire Medical Systems Inc. (INSP) · Health Care

Piper Sandler rates Inspire Medical Systems Inc. (INSP) Neutral with a $55 price target, as of its latest action on May 5, 2026. It has published 5 rating actions on INSP since July 2021, including 0 upgrades and 1 downgrade. Across 12 firms with a INSP price target in the last 12 months, the median target is $72. Piper Sandler's $55 is 24% below that.

Current rating
Neutral
Price target
$55
Median target, all firms
$72
Actions on INSP
5

Piper Sandler price target on INSP

$305$180$5520222023202420252026
Piper Sandler price target on INSP, each point a stated target, July 2021 to May 2026.

Every Piper Sandler rating on INSP

How other firms rate INSP

Each firm's latest rating and stated target in the last 12 months.

FirmRatingPrice targetDate
BarclaysUnderweight$65Oct 7, 2026
OppenheimerOutperform$85Aug 4, 2026
UBSSell$39Jul 28, 2026
Evercore ISIIn-line$40Jun 23, 2026
BofA SecuritiesUnderperform$39May 22, 2026
Piper SandlerNeutral$55May 5, 2026
Wolfe ResearchPeer Perform$180Feb 13, 2026
Robert W. BairdNeutral$74Feb 12, 2026
Wells FargoEqual Weight$70Feb 12, 2026
RBC Capital MarketsSector Perform$90Jan 27, 2026
Truist SecuritiesHold$96Jan 22, 2026
Morgan StanleyEqual-Weight$130Dec 2, 2025
StifelBuyNov 24, 2025

Questions about Piper Sandler and INSP

What is Piper Sandler's price target for INSP?
Piper Sandler's latest stated price target for Inspire Medical Systems Inc. (INSP) is $55, from its action on May 5, 2026.
What is Piper Sandler's rating on INSP?
Piper Sandler rates INSP Neutral, a neutral rating, as of May 5, 2026.
When did Piper Sandler last change its view on INSP?
On May 5, 2026, Piper Sandler downgrades to Neutral from Overweight, price target $55.
How does Piper Sandler's INSP target compare with other analysts?
Across 12 firms with a INSP price target in the last 12 months, the median target is $72. Piper Sandler's $55 is 24% below that.

More INSP rating histories

All Piper Sandler ratingsINSP news and filingsEvery analyst firm

From rating actions in the Quantisnow feed. A target holds until the firm states a new one; a reiteration with no target keeps the last one. Not investment advice.